SCIENCE IN THE NEWS DAILY
Study Suggests Drug Can Cut Risk of Cancer's Return
from the Baltimore Sun
CHICAGO (Associated Press) - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease.
It is the first large study to affirm wider anti-cancer hopes for Zometa and other bone-building drugs called bisphosphonates. Zometa, made by Novartis AG, is used now for cancers that have already spread to the bone.
The new study involved 1,800 premenopausal women taking hormone treatments for early-stage breast cancer. Zometa cut by one-third the chances that cancer would recur—in their bones or anywhere else.
Read more ...
Connect With Us:
Video: A Lone Gunman? Using Statistics in Forensics
Forensic scientists are often tasked to look for verification of what police officers already suspect, making bias a big problem.... (click the link above to read more).
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.